SFS
NKTR icon

Sowell Financial Services’s Nektar Therapeutics NKTR Stock Holding History

Sowell Financial Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-33
Closed -$8K – 3234
2020
Q4 		$8K Buy
33
+26
+371% +$6.72K ﹤0.01% 2118
2020
Q3 		$2K Sell
7
-10
-59% -$3.15K ﹤0.01% 2244
2020
Q2 		$6K Sell
17
-209
-92% -$65.2K ﹤0.01% 1845
2020
Q1 		$61K Sell
226
-164
-42% -$50.7K ﹤0.01% 986
2019
Q4 		$126K Buy
390
+388
+19,400% +$113K 0.01% 840
2019
Q3 		$0 Buy
+2
New +$733 ﹤0.01% 2429

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Sowell Financial Services's NKTR Position: Q1 2021 in Review

Sowell Financial Services sold out of Nektar Therapeutics (NKTR) in Q1 2021, closing a stake of 33 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in NKTR in Q3 2019 and held it in 6 quarters. The position peaked at $126K in Q4 2019. 236 funds tracked by Wall St. Rank hold NKTR as of Q1 2021.

  • Sowell Financial Services reported no remaining Nektar Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 33 Nektar Therapeutics shares in Q1 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Nektar Therapeutics in Q3 2019 and held it in 6 quarters.
  • Sowell Financial Services's Nektar Therapeutics position peaked at $126K in Q4 2019.
  • 236 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.